These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 29345747

  • 21. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [Abstract] [Full Text] [Related]

  • 22. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 23. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era.
    Kessler M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B.
    Am J Kidney Dis; 1996 Jul; 28(1):99-104. PubMed ID: 8712229
    [Abstract] [Full Text] [Related]

  • 24. The clinical course of IgA nephropathy after kidney transplantation and its management.
    Lionaki S, Panagiotellis K, Melexopoulou C, Boletis JN.
    Transplant Rev (Orlando); 2017 Apr; 31(2):106-114. PubMed ID: 28209246
    [Abstract] [Full Text] [Related]

  • 25. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.
    Avasare RS, Rosenstiel PE, Zaky ZS, Tsapepas DS, Appel GB, Markowitz GS, Bomback AS, Canetta PA.
    Am J Nephrol; 2017 Apr; 45(2):99-106. PubMed ID: 28056461
    [Abstract] [Full Text] [Related]

  • 26. Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation.
    Maixnerova D, Hruba P, Neprasova M, Bednarova K, Slatinska J, Suchanek M, Kollar M, Novak J, Tesar V, Viklicky O.
    Front Immunol; 2021 Apr; 12():726215. PubMed ID: 34659212
    [Abstract] [Full Text] [Related]

  • 27. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy.
    Park S, Baek CH, Cho H, Yu MY, Kim YC, Go H, Kim YH, Lee JP, Min SI, Ha J, Moon KC, Kim YS, Ahn C, Park SK, Lee H.
    Am J Transplant; 2019 Jan; 19(1):145-155. PubMed ID: 29718591
    [Abstract] [Full Text] [Related]

  • 28. Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    Lionaki S, Makropoulos I, Panagiotellis K, Vlachopanos G, Gavalas I, Marinaki S, Liapis G, Michelakis I, Bokos I, Boletis I.
    PLoS One; 2021 Jan; 16(8):e0253337. PubMed ID: 34403416
    [Abstract] [Full Text] [Related]

  • 29. A proliferation-inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients.
    Martín-Penagos L, Benito-Hernández A, San Segundo D, Sango C, Azueta A, Gómez-Román J, Fernández-Fresnedo G, López-Hoyos M, Ruiz JC, Rodrigo E.
    Clin Transplant; 2019 Apr; 33(4):e13502. PubMed ID: 30776158
    [Abstract] [Full Text] [Related]

  • 30. Renal transplantation in patients with primary immunoglobulin A nephropathy.
    Choy BY, Chan TM, Lo SK, Lo WK, Lai KN.
    Nephrol Dial Transplant; 2003 Nov; 18(11):2399-404. PubMed ID: 14551373
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Alemtuzumab Induction and Steroid Minimization in IgA Nephropathy: A Matched-Cohort Analysis.
    Becker K, Brooks J, Mitro G, Rees M, Ortiz J.
    Exp Clin Transplant; 2020 Dec; 18(7):751-756. PubMed ID: 31875465
    [Abstract] [Full Text] [Related]

  • 33. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS.
    Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
    [Abstract] [Full Text] [Related]

  • 34. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 35. Steroid withdrawal in renal transplantation.
    Grenda R.
    Pediatr Nephrol; 2013 Nov 20; 28(11):2107-12. PubMed ID: 23288351
    [Abstract] [Full Text] [Related]

  • 36. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT.
    Lemes-Canuto AP, de Sandes-Freitas TV, Medina-Pestana JO, Mastroianni-Kirsztajn G.
    J Ren Care; 2015 Dec 20; 41(4):222-30. PubMed ID: 25819382
    [Abstract] [Full Text] [Related]

  • 37. A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Barbour S, Djurdjev O, Gill JS, Dong JJ, Gill J.
    Kidney Int; 2019 Aug 20; 96(2):460-469. PubMed ID: 31248649
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK.
    Am J Kidney Dis; 2001 Sep 20; 38(3):588-96. PubMed ID: 11532693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.